From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)

• Zoltan Lohinai ,

  * E-mail: zoltan.lohinai@koranyi.hu

  Affiliations National Koranyi Institute of Pulmonology, Budapest, Hungary, Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, Arizona, United States of America

  ⨯
• Peter Dome,

  Affiliations Department of Clinical and Theoretical Mental Health, Kútvölgyi Clinical Center, Semmelweis University, Budapest, Hungary, National Institute of Psychiatry and Addictions, Budapest, Hungary

  ⨯
• Zsuzsa Szilagyi,

  Affiliation National Koranyi Institute of Pulmonology, Budapest, Hungary

  ⨯
• Gyula Ostoros,

  Affiliation National Koranyi Institute of Pulmonology, Budapest, Hungary

  ⨯
• Judit Moldvay,

  Affiliation National Koranyi Institute of Pulmonology, Budapest, Hungary

  ⨯
• Balazs Hegedus,

  Affiliations Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Molecular Oncology Research Group, Hungarian Academy of Sciences-Semmelweis University, Budapest, Hungary

  ⨯
• Balazs Dome ,

  Contributed equally to this work with: Balazs Dome, Glen J. Weiss

  ¶‡ BD and GJW are joint senior authors on this work.

  Affiliations National Koranyi Institute of Pulmonology, Budapest, Hungary, Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria

  ⨯
• Glen J. Weiss

  Contributed equally to this work with: Balazs Dome, Glen J. Weiss

  ¶‡ BD and GJW are joint senior authors on this work.

  Affiliation Western Regional Medical Center, Cancer Treatment Centers of America, Goodyear, Arizona, United States of America

  ⨯